CGTX icon

Cognition Therapeutics
CGTX

Overview Fund Activity

28 hedge funds and large institutions have $11.4M invested in Cognition Therapeutics in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 6 closing their positions.

Holders
28
Holders Change
+1
Holders Change %
+3.7%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
10
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PFO
1
Pathstone Family Office
New Jersey
$4.66M
2
ACM
2
AIGH Capital Management
Maryland
$2.38M
3
VC
3
Voss Capital
Texas
$653K
4
Commonwealth Equity Services
4
Commonwealth Equity Services
Massachusetts
$453K
5
PWM
5
Perigon Wealth Management
California
$259K

Top Sellers

1
KAS
1
Kestra Advisory Services
Texas
$32K
2
PM
2
Prosight Management
Texas
$254K
3
FWM
3
Frontier Wealth Management
Missouri
$0
4
Two Sigma Investments
4
Two Sigma Investments
New York
$0
5
AC
5
Apogem Capital
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BCA
26
Bray Capital Advisors
Florida
$5K 2,250 +2,250 New
TRCT
27
Tower Research Capital (TRC)
New York
$4K 1,907 +1,907 New
UBS Group
28
UBS Group
Switzerland
$2K 899 -2,850 -76%
FWM
29
Frontier Wealth Management
Missouri
– – -50,000 Closed
Two Sigma Investments
30
Two Sigma Investments
New York
– – -42,102 Closed
AC
31
Apogem Capital
New York
– – -17,667 Closed
Millennium Management
32
Millennium Management
New York
– – -14,536 Closed
Citadel Advisors
33
Citadel Advisors
Florida
– – -10,504 Closed
Barclays
34
Barclays
United Kingdom
– – -434 Closed
CFGS
35
Concourse Financial Group Securities
Alabama
– – – –
1
2